|
FAM123B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.138300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.327670E-02 |
| Normal-vs-Stage2 |
1.078610E-01 |
| Normal-vs-Stage3 |
7.964100E-04 |
| Normal-vs-Stage4 |
2.039400E-04 |
| Stage1-vs-Stage2 |
5.710200E-01 |
| Stage1-vs-Stage3 |
2.422000E-01 |
| Stage1-vs-Stage4 |
4.920400E-02 |
| Stage2-vs-Stage3 |
1.507970E-01 |
| Stage2-vs-Stage4 |
4.424300E-02 |
| Stage3-vs-Stage4 |
4.083200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.237700E-03 |
| Normal-vs-AfricanAmerican |
1.297790E-02 |
| Normal-vs-Asian |
6.977200E-03 |
| Caucasian-vs-AfricanAmerican |
5.143400E-01 |
| Caucasian-vs-Asian |
7.816200E-01 |
| AfricanAmerican-vs-Asian |
6.331600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.029320E-04 |
| Normal-vs-Female |
9.056100E-03 |
| Male-vs-Female |
8.761700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.245960E-02 |
| Normal-vs-Age(41-60Yrs) |
7.918200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.957000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.298400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.839600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.313800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.249800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.437800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.850800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.742800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.657600E-03 |
| Classical-VS-Follicular |
2.280200E-01 |
| Classical-VS-Other |
1.143810E-01 |
| Classical-VS-Normal |
2.576300E-02 |
| Tall-VS-Follicular |
9.465800E-02 |
| Tall-VS-Other |
6.551000E-01 |
| Tall-VS-Normal |
1.011430E-04 |
| Follicular-VS-Other |
1.979620E-01 |
| Follicular-VS-Normal |
2.977400E-03 |
| Other-VS-Normal |
1.095980E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.800090E-02 |
| Normal-vs-N1 |
7.53580000000253E-05 |
| N0-vs-N1 |
3.038300E-02 |
|
|
